<DOC>
	<DOCNO>NCT00996489</DOCNO>
	<brief_summary>This post approval study Coaptite® treatment female urinary incontinence .</brief_summary>
	<brief_title>Post Approval Study Coaptite® Treatment Female Urinary Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<criteria>Has female stress urinary incontinence due intrinsic sphincter deficiency Has baseline pad weight great equal 50 gram Has viable mucosal line likely site injection ( bladder neck ) Is least 18 year age Understands accepts obligation logistically able present schedule study visit Signs write informed consent Has previous treatment urinary incontinence urethral bulking agent Coaptite® collagen Has detrusor instability Has bladder neuropathy Has nocturnal enuresis ( bed wet ) Has Grade II III prolapse bladder Has overflow functional incontinence Has significant history urinary tract infection without resolution Has current acute condition cystitis urethritis Has history significant pelvic irradiation Is pregnant lactate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>